查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572101

耳迷迷走神經刺激設備市場：按設備類型、應用、最終用戶、分銷管道分類 - 全球預測 2025-2030

Auricular Vagus Nerve Stimulation Devices Market by Device Type (External Devices, Implantable Devices), Application (Depression, Epilepsy, Pain Management), End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年耳迷迷走神經刺激設備市值為3.6987億美元，預計2024年將達到3.9256億美元，複合年成長率為5.94%，到2030年將達到5.5421億美元，預計將達到1000萬美元。

耳迷走神經刺激 (aVNS) 裝置是神經調節療法的重要進步，重點在於位於耳外的迷走神經。這些設備被定義為攜帶式、非侵入性設備，旨在刺激迷走神經的耳支，為許多健康狀況提供治療益處，包括癲癇、憂鬱症和慢性疼痛。對 aVNS 設備的需求突出是因為它們有潛力提供一種非藥物治療選擇，可以減輕藥物相關的副作用。這些設備主要應用於醫療保健行業，特別是神經病學和精神病學，為醫院、神經科學診所和尋求家庭治療的個別患者等最終用戶提供服務。神經系統疾病的增加、對微創治療的日益偏好以及監管部門批准的增加推動了市場成長。最新的商機在於擴大研究和開發，旨在使應用領域多樣化，例如METABOLIC INC.症候群和壓力相關疾病。為了抓住這些機會，公司應該專注於臨床試驗並與醫療保健提供者密切合作，以檢驗設備的功效和安全性。然而，市場擴張受到設備成本高、法律規範嚴格以及潛在用戶和醫療保健專業人員認知度低等挑戰的阻礙。 aVNS 設備的創新應旨在降低成本、增強用戶介面並整合穿戴式技術，以提高設備的可訪問性和便利性。此外，與高科技公司的合作可以透過整合人工智慧和機器學習來提供個人化的治療方案，從而刺激創新。市場的快節奏需要持續監控並適應不斷變化的法規和技術進步。位於醫療保健和技術交叉領域並專注於客製化患者照護解決方案的公司準備充分利用 aVNS 設備不斷變化的需求。

主要市場統計
基準年[2023] 36987萬美元
預測年份 [2024] 3.9256 億美元
預測年份 [2030] 5.5421億美元
複合年成長率（%） 5.94%

市場動態：快速發展的耳迷迷走神經刺激設備市場的關鍵市場洞察

耳迷迷走神經刺激設備市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 越來越多的慢性疾病需要有效的神經調節療法
    • 加大醫療設備創新研發投入
    • 提高醫療保健專業人員和患者對神經刺激療法的認知和接受度
    • 微創技術的進步促進迷走神經刺激設備的採用
  • 市場限制因素
    • 耳迷迷走神經刺激設備的高成本阻礙了市場滲透
  • 市場機會
    • 慢性疾病的盛行率不斷增加，需要先進的耳迷走神經刺激解決方案
    • 人口老化的擴大推動了非藥物療法的採用，包括耳迷走神經刺激
    • 人們對心理健康意識的提高推動了對耳迷迷走神經刺激設備的需求
  • 市場挑戰
    • 有限的臨床證據影響醫療保健專業人員的可信度和可接受性

波特的五力：駕馭耳迷走迷走神經刺激設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解耳迷迷走神經刺激設備市場的外部影響

外部宏觀環境因素在塑造耳迷迷走神經刺激設備市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解迷走神經刺激設備市場的競爭狀況

對耳迷迷走神經刺激設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣耳迷迷走神經刺激設備市場供應商的績效評估

FPNV 定位矩陣是評估耳迷迷走神經刺激設備市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了迷走神經刺激設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對耳迷走迷走神經刺激設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 越來越多的慢性疾病需要有效的神經調節療法
      • 加大醫療設備創新研發投入
      • 醫療保健專業人員和患者對神經刺激療法的認知和接受度正在提高
      • 微創技術的進步促進了迷走神經刺激設備的採用
    • 抑制因素
      • 耳迷迷走神經刺激設備的高成本阻礙了廣泛的市場滲透
    • 機會
      • 越來越多的慢性疾病需要先進的耳迷走神經刺激解決方案
      • 隨著人口老化的增加，諸如耳迷走神經刺激療法等非藥物治療方法被引入。
      • 人們對心理健康的認知不斷提高，推動了對耳迷迷走神經刺激設備的需求
    • 任務
      • 有限的臨床證據影響醫療保健專業人員的可信度和接受度
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章耳迷迷走神經刺激設備市場（以設備類型）

  • 外部設備
    • 電極
    • 動力裝置
  • 植入式裝置
    • 生物感測器

第7章耳迷迷走神經刺激設備市場：依應用分類

  • 憂鬱症
  • 癲癇
  • 疼痛管理
    • 慢性疼痛
    • 偏頭痛
  • 耳鳴

第8章耳迷迷走神經刺激設備市場：依最終用戶分類

  • 家庭護理設置
  • 醫院
    • 住院病人
    • 門診病人

第9章耳迷迷走神經刺激設備市場：按分銷管道

  • 直銷
  • 經銷商
  • 網路零售

第10章美洲耳迷迷走神經刺激設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區耳迷迷走神經刺激設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲耳迷走迷走神經刺激設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-546E6FBB35F7

The Auricular Vagus Nerve Stimulation Devices Market was valued at USD 369.87 million in 2023, expected to reach USD 392.56 million in 2024, and is projected to grow at a CAGR of 5.94%, to USD 554.21 million by 2030.

Auricular Vagus Nerve Stimulation (aVNS) devices represent a significant advancement in neuromodulation therapies, focusing on the external vagus nerve located in the ear. These devices encompass a scope that includes definition as portable and non-invasive instruments designed to stimulate the auricular branch of the vagus nerve, providing therapeutic benefits for a multitude of health conditions like epilepsy, depression, and chronic pain. The necessity of aVNS devices is underscored by their potential to offer non-drug treatment alternatives that can reduce side effects associated with pharmaceuticals. These devices are predominantly applied in the healthcare industry, particularly in neurology and psychiatry, serving end-users such as hospitals, neurological clinics, and individual patients seeking home-based therapies. Market growth is powered by rising incidences of neurological disorders, escalating preference for minimally invasive treatments, and increasing regulatory approvals. The latest opportunities lie in expanding research and development efforts to diversify application areas, such as metabolic syndrome and stress-related ailments. To seize these opportunities, businesses should focus on clinical trials and strong collaborations with healthcare providers to validate device efficacy and safety. However, market expansion is hindered by challenges like high device costs, stringent regulatory frameworks, and a paucity of awareness among potential users and healthcare practitioners. Innovation in aVNS devices should target cost reduction, enhancing user interface, and integrating wearable technology to improve device accessibility and convenience. Moreover, partnerships with tech firms can spur innovation by integrating artificial intelligence and machine learning for personalized treatment options. The market's fast-paced nature demands continuous monitoring and adaptation to changing regulations and technological advancements. Businesses positioning themselves at the intersection of healthcare and technology, with an emphasis on customized patient care solutions, are poised to capitalize on the evolving demand for aVNS devices.

KEY MARKET STATISTICS
Base Year [2023] USD 369.87 million
Estimated Year [2024] USD 392.56 million
Forecast Year [2030] USD 554.21 million
CAGR (%) 5.94%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Auricular Vagus Nerve Stimulation Devices Market

The Auricular Vagus Nerve Stimulation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases requiring effective neuromodulation therapies
    • Growing investments in research and development for medical device innovation
    • Rising awareness and acceptance of neurostimulation therapies among healthcare professionals and patients
    • Advancements in minimally invasive techniques enhancing the adoption of vagus nerve stimulation devices
  • Market Restraints
    • High costs of auricular vagus nerve stimulation devices deterring widespread market penetration
  • Market Opportunities
    • Increasing prevalence of chronic diseases demanding advanced auricular vagus nerve stimulation solutions
    • Expanding aging population driving adoption of non-pharmacological therapies including auricular vagus nerve stimulation
    • Rising awareness about mental health pushing demand for auricular vagus nerve stimulation devices
  • Market Challenges
    • Limited clinical evidence affecting the credibility and acceptance among healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Auricular Vagus Nerve Stimulation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Auricular Vagus Nerve Stimulation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Auricular Vagus Nerve Stimulation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Auricular Vagus Nerve Stimulation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Auricular Vagus Nerve Stimulation Devices Market

A detailed market share analysis in the Auricular Vagus Nerve Stimulation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Auricular Vagus Nerve Stimulation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Auricular Vagus Nerve Stimulation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Auricular Vagus Nerve Stimulation Devices Market

A strategic analysis of the Auricular Vagus Nerve Stimulation Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Auricular Vagus Nerve Stimulation Devices Market, highlighting leading vendors and their innovative profiles. These include Bioness Inc., ElectroCore, Inc., LivaNova PLC, Medtronic plc, MicroTransponder Inc., Nervana LLC, NeuroPace, Inc., Neuros Medical, Inc., NeuroSigma, Inc., parasym Limited, ReShape Lifesciences Inc., SetPoint Medical, Soterix Medical Inc., and tVNS Technologies GmbH.

Market Segmentation & Coverage

This research report categorizes the Auricular Vagus Nerve Stimulation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across External Devices and Implantable Devices. The External Devices is further studied across Electrodes and Power Units. The Implantable Devices is further studied across Biosensors.
  • Based on Application, market is studied across Depression, Epilepsy, Pain Management, and Tinnitus. The Pain Management is further studied across Chronic Pain and Migraine.
  • Based on End User, market is studied across Homecare Settings and Hospitals. The Hospitals is further studied across In-Patient and Out-Patient.
  • Based on Distribution Channel, market is studied across Direct Sales, Distributors, and Online Retail.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases requiring effective neuromodulation therapies
      • 5.1.1.2. Growing investments in research and development for medical device innovation
      • 5.1.1.3. Rising awareness and acceptance of neurostimulation therapies among healthcare professionals and patients
      • 5.1.1.4. Advancements in minimally invasive techniques enhancing the adoption of vagus nerve stimulation devices
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of auricular vagus nerve stimulation devices deterring widespread market penetration
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing prevalence of chronic diseases demanding advanced auricular vagus nerve stimulation solutions
      • 5.1.3.2. Expanding aging population driving adoption of non-pharmacological therapies including auricular vagus nerve stimulation
      • 5.1.3.3. Rising awareness about mental health pushing demand for auricular vagus nerve stimulation devices
    • 5.1.4. Challenges
      • 5.1.4.1. Limited clinical evidence affecting the credibility and acceptance among healthcare professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Auricular Vagus Nerve Stimulation Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. External Devices
    • 6.2.1. Electrodes
    • 6.2.2. Power Units
  • 6.3. Implantable Devices
    • 6.3.1. Biosensors

7. Auricular Vagus Nerve Stimulation Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Depression
  • 7.3. Epilepsy
  • 7.4. Pain Management
    • 7.4.1. Chronic Pain
    • 7.4.2. Migraine
  • 7.5. Tinnitus

8. Auricular Vagus Nerve Stimulation Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Homecare Settings
  • 8.3. Hospitals
    • 8.3.1. In-Patient
    • 8.3.2. Out-Patient

9. Auricular Vagus Nerve Stimulation Devices Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Direct Sales
  • 9.3. Distributors
  • 9.4. Online Retail

10. Americas Auricular Vagus Nerve Stimulation Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Auricular Vagus Nerve Stimulation Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bioness Inc.
  • 2. ElectroCore, Inc.
  • 3. LivaNova PLC
  • 4. Medtronic plc
  • 5. MicroTransponder Inc.
  • 6. Nervana LLC
  • 7. NeuroPace, Inc.
  • 8. Neuros Medical, Inc.
  • 9. NeuroSigma, Inc.
  • 10. parasym Limited
  • 11. ReShape Lifesciences Inc.
  • 12. SetPoint Medical
  • 13. Soterix Medical Inc.
  • 14. tVNS Technologies GmbH

LIST OF FIGURES

  • FIGURE 1. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY ELECTRODES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY POWER UNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY TINNITUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IN-PATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY OUT-PATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 169. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 177. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 185. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 197. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 200. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 207. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 226. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 234. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 239. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 240. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 242. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 245. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 248. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 250. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 258. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 263. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 264. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 266. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 274. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MA